Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

Completed · Phase 1

Conditions studied: Atopic Disorders, Eczema, Atopic

In brief

To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).

Key facts

Study ID

NCT03050151

Run by

Regeneron Pharmaceuticals

People needed

176

Starts

2017-02-28

Expected to finish

2018-02-12

Last updated by the study team

2018-08-01

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Regeneron Investigational Site — Birmingham, Alabama, United States
• Regeneron Investigational Site — Birmingham, Alabama, United States
• Regeneron Investigational Site — Fort Smith, Arkansas, United States
• Regeneron Investigational Site — Long Beach, California, United States
• Regeneron Investigational Site — Los Angeles, California, United States
• Regeneron Investigational Site — Murrieta, California, United States
• Regeneron Investigational Site — Oceanside, California, United States
• Regeneron Investigational Site — Orange, California, United States
• Regeneron Investigational Site — Rolling Hills Estates, California, United States
• Regeneron Investigational Site — Santa Monica, California, United States
• Regeneron Investigational Site — Denver, Colorado, United States
• Regeneron Investigational Site — Coral Gables, Florida, United States
• Regeneron Investigational Site — Tampa, Florida, United States
• Regeneron Investigational Site — Normal, Illinois, United States
• Regeneron Investigational Site — Skokie, Illinois, United States
• Regeneron Investigational Site — Indianapolis, Indiana, United States
• Regeneron Investigational Site — Rockville, Maryland, United States
• Regeneron Investigational Site — Plymouth, Minnesota, United States
• Regeneron Investigational Site — Saint Joseph, Missouri, United States
• Regeneron Investigational Site — Berlin, New Jersey, United States
• Regeneron Investigational Site — Windsor, New Jersey, United States
• Regeneron Investigational Site — Corning, New York, United States
• Regeneron Investigational Site — Forest Hills, New York, United States
• Regeneron Investigational Site — New York, New York, United States
• Regeneron Investigational Site — High Point, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.